Statin-associated rhabdomyolysis in a patient with liver cirrhosis due to primary sclerosing cholangitis on the liver transplant waiting list – an instructive case

Background and objective: Statins are increasingly recommended in patients with liver cirrhosis due to their cardiovascular benefits and potential positive effects on portal hypertension and overall survival. However, patients with advanced cirrhosis are at increased risk for statin-associated muscle [for full text, please go to the a.m. URL]